Key facts
- This page summarizes Wayne Linsley's Form 4 filing for Hoth Therapeutics, Inc. (HOTH).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 18 Mar 2022, 16:15.
Wayne Linsley - 16 Mar 2022 Form 4 Insider Report for Hoth Therapeutics, Inc. (HOTH)
- Role
- Director
- Signature
- /s/ Jane H. Springer as Attorney-In-Fact for Wayne Linsley
- Issuer symbol
- HOTH
- Transactions as of
- 16 Mar 2022
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 18 Mar 2022, 16:15:34 UTC
- Previous filing
- 05 Jan 2022
- Next filing
- 18 Jul 2023
- SEC
- View on sec.gov
Key filing fact
Wayne Linsley filed Form 4 for Hoth Therapeutics, Inc. (HOTH) on 18 Mar 2022.
Change
- Previous filing in this sequence was filed on 05 Jan 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
HOTH
transaction
Derivative
Options
Award
- Transaction value
- $0
- Shares
- +40,000
- Change %
- Price
- $0.000000
- Shares after
- 40,000
- Date
- 16 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 40,000
- Exercise price
- $0.5910
- Footnotes
- F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The options were issued pursuant to the Issuer's 2018 Equity Incentive Plan and vested in full upon grant. |